Y-mAbs Therapeutics, Inc.

We are excited to be part of Children’s Oncology Group Fall Meeting in New Orleans, LA from September 24 – 27, 2024! Swing by our booth and let's connect! #COGFall2024 #Ymabs #PediatricCancer #RareDiseaseAwareness #childhoodcancer #cancerawareness #pediatriconcology

During Childhood Cancer Awareness Month, organizations around the world unite to raise awareness about pediatric cancer and support the families impacted by the disease. At Y-mAbs Therapeutics, Inc., our work in advancing innovative antibody-based therapies is driven by the belief that every child deserves a chance at a healthy future. We are proud to serve as a partner to The EVAN Foundation in support of their mission to help kids with cancer have a brighter today and a better tomorrow. We are thankful for their tireless work and the moments of joy they bring to patients and their families. Together, we can help transform lives. For additional information and to learn more about The EVAN Foundation, visit: https://bit.ly/4dc110v #ChildhoodCancerAwarenessMonth #CCAM #PediatricOncology #Neuroblastoma

Our President and CEO Michael Rossi will participate in a fireside chat at the 2024 Cantor Fitzgerald Healthcare Conference today, September 17th, at 3:40 p.m. ET. Join the conversation as we share insights into the latest advancements that drive our mission to improve cancer treatments for patients. Access the live audio webcast here: https://bit.ly/3TuwuE6 #CantorHCC

Ready to connect at APHON in Salt Lake City, UT from September 10 – 13, 2024? Stop by booth #301 and say hi! https://lnkd.in/gBrVygpB #APHON2024 #Ymabs #pediatriccancer #rarediseaseawareness #childhoodcancer #cancerawareness #pediatriconcology

At Y-mAbs Therapeutics, Inc., the fight against childhood cancer, the leading cause of death by disease for children in the U.S., is personal. We are driven every day by the patients and caregivers impacted by these cancers as we work to push through the boundaries of what’s possible. This Childhood Cancer Awareness Month, we reaffirm our commitment to advance and deliver novel therapies that give childhoods back to patients and children back to their families.    This month, we invite you to join us in our mission to raise awareness and bring hope to children and families fighting cancer. Let’s work together to expand access to the treatments that can change lives.   Visit the American Childhood Cancer Organization (ACCO) website for additional information and resources: https://bit.ly/44MWEVt   #ChildhoodCancerAwarenessMonth #CCAM #PediatricOncology #Neuroblastoma  

Our President and CEO, Michael Rossi, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference this Friday, September 6th at 1:50 p.m. ET. Tune in to hear the latest developments in our mission of advancing novel therapies through clinical development to improve patient lives.   Register for the live audio webcast here: https://bit.ly/4cYN8CY

Radiopharmaceuticals have shown promise in their potential to revolutionize the treatment landscape in oncology and beyond. Interested in learning from Y-mAbs Therapeutics, Inc. CEO Michael Rossi at #SXSW2025 in Austin, TX on the current state of the field, advantages over traditional cancer treatments, and hear compelling insights into future innovations and technology advancements? Vote by August 18, 2024 using the #PanelPicker link here: https://bit.ly/3Yzm75t #SXSW #SXSW25 #Radiopharmaceuticals #Radiotherapies #Oncology #Cancer

Today, we reported financial results and operational updates for the second quarter of 2024. The entire Y-mAbs Therapeutics, Inc. team remains steadfast in our shared mission of improving patient lives by advancing our novel therapies through clinical development. View our full press release here: https://bit.ly/4cp7Uvd. To listen to the replay of our webcast, visit: https://bit.ly/4fJOX9a

Y-mAbs Therapeutics, Inc. is thrilled to welcome Peter Pfreundschuh as our new Chief Financial Officer and Norman LaFrance, M.D. as our Chief Development Officer. These additions further strengthen our leadership team as we work to advance our mission of improving the lives of patients with cancer and other serious diseases. Join us in welcoming Peter and Norman!   Read more about Peter here https://bit.ly/4eI6qhL and Norman here https://bit.ly/4cHp3Av   #Radiotherapy #Radiopharmaceuticals #ChildhoodCancer #PediatricOncology

We’re excited to gather at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting in Toronto, Canada starting tomorrow, June 8th through June 11th, where we will present a poster highlighting preclinical GD2-SADA data. Swing by booth #1845 and let's chat about making a difference! Read our press release for more information: https://lnkd.in/eyH7kJ8i #SNMMI #SNMMI24 #Radiotherapy